Transcriptional mutagenesis in mammalian cell systems p53 signaling as a probe...
Transcriptional mutagenesis in mammalian cell systems p53 signaling as a probe of cellular effects
The process of misincorporation of incorrect bases into the nascent RNA as a result of DNA-lesion bypass by RNA polymerases during transcription is referred to as transcriptional mutagenesis (TM). Although this has been shown to a...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2014-53467-R
ESTUDIO DE LA INTERACCION ENTRE RUTAS DE SEÑALIZACION MEDIAD...
157K€
Cerrado
BFU2015-69709-P
PROCESOS REVERSIBLES EN EL CONTROL DEL CICLO CELULAR: UBIQUI...
142K€
Cerrado
SAF2014-52162-P
PAPEL DEL COMPLEJO INHIBIDOR RPL5/RPL11/5S RRNA EN EL CCR DI...
424K€
Cerrado
BFU2013-48374-P
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF TRANSCRIPTION...
260K€
Cerrado
BFU2016-77081-P
IMPORTANCIA DE LAS PROTEINAS FOSFATASAS EN LA REGULACION ESP...
121K€
Cerrado
TF3B_P3
Structural characterization of TFIIIB and its involvement in...
167K€
Cerrado
Información proyecto TMP53COMPMIX
Líder del proyecto
KAROLINSKA INSTITUTET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
100K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The process of misincorporation of incorrect bases into the nascent RNA as a result of DNA-lesion bypass by RNA polymerases during transcription is referred to as transcriptional mutagenesis (TM). Although this has been shown to alter the subsequent proteins function, the relative importance of TM in human health is virtually untouched. I propose to study the cellular effects and biological significance of TM using the tumor suppressor protein p53 as probe. The choice of p53 is based on its role as a guardian of the genome regulating life or death of cells. The objective will be achieved by developing novel expression constructs containing site-specific DNA damage yielding transcripts encoding mutant p53 protein. This will in part be done in a continued collaboration with my former post doctoral mentor at New York University, USA. The vectors will be transiently transfected into mammalian cells and the TM of p53 and the cellular effects on e.g. cell-cycle progression and viability studied. Furthermore, cellular model system will be utilized to study the potential effects of TM on the cellular response to a toxic insult. The model is based on the central role of p53 in the cellular response to DNA damages derived from carcinogenic polycyclic aromatic hydrocarbons (PAHs). Transfected cells exposed to complex PAH mixtures will be assayed with regard to relevant endpoints including; p53 down-stream signaling events and expression, cell cycle regulation and DNA repair. The results will be analyzed in relation to the p53 protein status. The use of PAH mixtures is motivated by the increasing interest by the European community in developing strategies for risk assessment of complex mixtures. The proposed project will take place at Karolinska Institutet, Sweden, ranked as one of the world’s leading biomedical universities with a strong European dimension, thus an excellent host in pursuing my Europe-oriented career plans.